Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAOIB and tDCS for Early-phase Dementia
NCT04737096Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daoib in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Chang Gung Memorial Hospital. Started Jan 2020; status: completed.
02
Drugs
daoib
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT04737096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737096.